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Abstract
Objective: To identify and investigate the susceptibility genes of Kashin–Beck disease (KBD) in Chinese population.
Methods: Whole-exome capturing and sequencing technology was used for the detection of genetic variations in 19
individuals from six families with high incidence of KBD. A total of 44 polymorphisms from 41 genes were genotyped from a
total of 144 cases and 144 controls by using MassARRAY under the standard protocol from Sequenom. Association was
applied on the data by using PLINK1.07.
Results: In the sequencing stage, each sample showed approximately 70-fold coverage, thus covering more than 99% of the
target regions. Among the single nucleotide polymorphisms (SNPs) used in the transmission disequilibrium test, 108 had a
p-value of,0.01, whereas 1056 had a p-value of,0.05. Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway analysis
indicates that these SNPs focus on three major pathways: regulation of actin cytoskeleton, focal adhesion, and metabolic
pathways. In the validation stage, single locus effects revealed that two of these polymorphisms (rs7745040 and rs9275295)
in the human leukocyte antigen (HLA)-DRB1 gene and one polymorphism (rs9473132) in CD2-associated protein (CD2AP)
gene have a significant statistical association with KBD.
Conclusions: HLA-DRB1 and CD2AP gene were identified to be among the susceptibility genes of KBD, thus supporting the
role of the autoimmune response in KBD and the possibility of shared etiology between osteoarthritis, rheumatoid arthritis,
and KBD.
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Introduction
Kashin–Beck disease (KBD) is a chronic, endemic osteochon-
dropathy distributed mainly in a limited area from southeastern
Siberia extending to northeast and southwest China[1]. According
to the 2010 Health Statistical Yearbook of China, approximately
690,000 patients have been diagnosed with KBD, and more than
10 million people have a high risk of being affected in 366 counties
within 14 provinces or autonomous regions of China[2].
Biogeochemical risk factors such as endemic selenium deficiency,
high humic acid levels in drinking water, and contamination of
mycotoxin-producing fungi in cereal have long been found to
cause KBD [3–7]. However, the pathogenesis of KBD remains
unknown. An increasing body of evidence suggests that environ-
mental factors cannot solely account for the etiology of KBD [2].
Over the past few years, a number of studies provided evidence
that KBD is a disease that is made complex by interactions
between environmental factors and susceptible genes of the disease
[3,9–11]. For example, four candidate selenoprotein genes
including GPX1, TrxR2, SEPP1, and DIO2 were analyzed for
161 KBD patients and 312 controls. Results indicated that the
GPX1Leu allele can be associated with higher KBD risk [3].
Other studies on candidate genes have shown that genetic variants
of human leukocyte antigen (HLA)-DRB1, which mainly causes
osteoarthritis (OA) and rheumatoid arthritis (RA), were also
associated with KBD [12–16]. Genome-wide gene expression
analysis also suggested that chronic hypoxia-induced mitochon-
drial damage and apoptosis might be an important factor in the
pathogenesis of KBD [4].
Although these previous studies may partially reveal several
causes of KBD, no consistent conclusions have been drawn to
identify the real pathogenic factors. The genetic contributions of
this disease should be uncovered. Recent advanced analysis in
whole-exome sequencing enabled an unbiased investigation of the
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complete protein-coding and flanking regions of the genome [5].
This technology has been successfully applied in the identification
of Mendalian disorder [6] and has been proposed as a method for
phenotypically complicated, genetically heterogeneous disorders
when traditional linkage studies were unsuccessful [7].
In this study, 19 individuals from six multiple-affected KBD
families were selected initially for whole-exome sequencing for the
detection of functional genetic variation, which may be susceptible
to KBD. The preliminary findings were then followed by
association analysis in a larger independent case-control sample
established to validate variants from significant sequencing signals
and candidate genes derived from Kyoto Encyclopedia of Genes
and Genomes (KEGG) pathway analysis.
Methods
Study Design and Subjects
The study was approved by the Ethics Committee of the West
China Hospital of Sichuan University. All next of kin, care takers
or guardians consented on the behalf of participants to provid
written informed consent for their participation. We used the
following criteria to evaluate whether the participants had the
capacity to consent: Firstly, patients have the ability to understand;
Secondly, patients have the ability to know reason; Thirdly,
patients have the ability to make rational decisions. If participants
failed to fill out the consent form more than twice, their guardians
were asked to fill out the consent on the behalf of patients.
This study was designed with two stages, including whole-
exome sequencing on family-based analysis and validation in an
independent sample set. Six families with multiple KBD patients
were recruited from the endemic Nai Dang Village, Jin Chuan
County, Aba Autonomous Prefecture of Sichuan Province, China.
Detailed information on these family samples is listed in Table 1.
Patients were examined when they were .=5-year old and were
diagnosed with KBD based on the following symptoms: persistent
pain; limitation of mobility; deformity of the fingers, toes, knees,
ankles, wrists, interphalangeal joint, hips, or shoulders; specific
changes on X-ray photography [8]; lack of other arthritis diseases
such as RA, OA, or local inflammation; and lack of a history of
trauma [1,9]. All participants are Han Chinese.
In the validation stage, a total of 144 cases of KBD and 144
matched healthy controls were recruited from the same popula-
tions in other endemic villages in Jin Chuan County.
Whole-exome Capturing and Sequencing
Peripheral blood (5 ml) was collected from all participants, and
genomic DNA was extracted according to a standard phenol–
chloroform procedure. NimbleGenSeqCap EZ Exome v2.0 was
used for exome capture. The exome capture kits were purchased
from the manufacturer [10]. Exome capture libraries were
constructed following the manufacturers’ standard protocol with
optimized parameters. Sequencing was conducted on Illumina
HiSeq2000 as paired-end 90 bp reads (PE90) after indexing and
pooling libraries. Each library was sequenced to a depth providing
approximately 60-fold mapped coverage on target regions. Raw
image files were processed by using the Illumina pipeline
(version1.3.4) for base-calling and for the generation of a raw
read set.
Exome Capture Data Analysis
Adapter contamination and reads with low quality were
identified and then removed before mapping. Reads were aligned
to human genome reference GRCh37 by using SOAP (v2.21)[11].
Consensus genotypes were called for loci on target regions and
nearby (200 bp upstream/downstream) by using SOAPsnp [12].
SNPs were extracted, and those with low confidence were
removed. All the dataset were deposited in NCBI SRA, and
accession ID is SRP035444.
Validation Genotyping in a Larger Sample Set
44 SNPs from 41 genes were selected for validation. Among
them, 12 SNPs enrichment in chromosome 19 and other regions
show lower P value were selected firstly. There pathways shows
more interesting associated with KBD after KEGG pathway
analysis [13], and 12 SNPs in Focal adhesion, 4 SNPs in metabolic
pathway, also 3 SNPs in regulation of actin cytoskeleton were
validated further. In addition, previous studies on Kashin–Beck
susceptibility loci [12,17,26–28] indicated that gene in immune
system may associated with KBD. So, 3 SNPs in HLA-DRB1 and
10 SNPs present significant in current study of immune related
genes validated further. In total, 44 SNPs from 41 genes (Table S1)
were employed for the association test, with 288 samples from the
same population.
The samples were genotyped by using MassARRAY [14] under
the standard protocol from Sequenom. Both SNPs and samples
with a call rate of ,90% were excluded in the data analysis. Case-
control association analysis was conducted based on the genotyp-
ing data by using PLINK1.07 (http://pngu.mgh.harvard.edu/
purcell/plink). Bonferroni correction was used to reduce the false
positive introduced by multi-test [15]. SNP on gene function
annotation used SIFT tools (http://www.snp-nexus.org/).
Results
Exome Capture Data Analysis
A total of 124 gigabases (Gb) of DNA sequence were generated,
with an average of 6.5 Gb per sample (Table 2). Each sample has
approximately 70-fold coverage of the target regions, thus
covering more than 99% of the target regions. For each sample,
approximately 95% of the target regions with no less than 10-fold
coverage were obtained. Results suggest that these regions are
expected to have high-confidence genotypes.
Among the 78,458,750 high-confidence genotypes, 90,197 high-
confidence SNPs were obtained for each sample. All these SNPs
were located at the 188,342 SNP loci. Among these SNP loci,
181,870 only had two alleles on autosomes. These SNPs were then
used in the transmission disequilibrium test (TDT), in which 108
and 1056 SNPs have p-values of ,0.01 and ,0.05, respectively
(Figure S1 and Table S4). The most significant p-value site
distribution concentrated on the 19q13.2 (chr19: 38742846-
54254388), which contains the selenoprotein V (SELV) and
transfer RNA selenocysteine 1 (TRNAU1) gene. In this study,
IL4R, CD22, CD82, CD163L1, CD180, IL12A, HLA-F-AS1,
CD2AP, and HLA-DPB1 genes were found to show a positive
association with KBD. KEGG pathway analysis (http://bioinfo.
vanderbilt.edu/webgestalt/option.php) indicates that a large
number of genes with significant statistical difference focused on
three major pathways: regulation of actin cytoskeleton, focal
adhesion, and metabolic pathways (Table S2).
Validation in a Larger Sample Set
Demographic characteristics of the sample set showed no
significant difference in gender distribution between patients with
KBD (58 males and 86 females) and healthy controls (66 males
and 78 females) (x2 = 0.906, p= 0.34). No significant difference in
age distribution was found between patients with KBD
(59.98611.13 years) and healthy controls (57.53610.23 years)
(t = 1.94, p = 0.053).
Genetic Susceptibility of Kashin-Bexk Disease
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Out of 44 loci and 288 samples, 43 (97.7%) and 283 (98.3%)
passed the aforementioned filter criteria of 90%[14]. Genotype
distribution in both cases with KBD and controls did not deviate
from the Hardy–Weinberg equilibrium. Analysis for single locus
effects reveals that two SNPs (rs7745040 and rs9275295) in the
HLA-DRB1 gene and one SNP (rs9473132) in the CD2AP gene
had a significant statistical association with KBD. This result was
obtained when SNPs were analyzed by genotype and allele
frequencies (p-value ,0.001 for all SNPs by analysis of either
genotypes or alleles, Bonferroni adjusted significance level)
(Table 3).
Discussion
In this study, a number of possible genes were initially found to
be associated with KBD, including genes of inflammatory factors,
SELV and TRNAU1 genes, as well as genes derived from three
related pathways (regulation of actin cytoskeleton, focal adhesion,
Table 1. Detailed information on all sequencing samples.
Family No. Individual No. Sex (Male/Female) Age Affected (clinical grades of KBD)/Unaffected
Family 1 A0001 (Father) M 69 Affected (I)
A0002 (Mother) F 68 Unaffected
A0123 (Daughter) F 44 Affected (II)
Family 2 A0169 (Father) M 43 Unaffected
A0170 (Mother) F 39 Affected (I)
A0171 (Son) M 17 Affected (I)
Family 3 A0306 (Father) M 54 Affected (I)
A0307 (Mother) F 51 Unaffected
A0308 (Daughter) F 22 Affected (I)
Family 4 A0463 (Father) M 66 Unaffected
A0464 (Mother) F 63 Unaffected
A0467 (Son) M 35 Affected (I)
Family 5 A0521 (Father) M 69 Affected (I)
A0522 (Mother) F 67 Unaffected
A0523 (Son) M 39 Affected (I)
Family 6 A0527 (Father) M 49 Unaffected
A0528 (Mother) F 46 Unaffected
A0530 (Son) M 19 Affected (II)
A0531 (Daughter) F 17 Affected (I)
Note: Diagnosis and grading standards according to Moreno-Reyes, R et al[28]. I denotes mild, IIdenotes moderate, and III denotes severe.
doi:10.1371/journal.pone.0092298.t001
Table 2. Exome capture statistics.
Male Female Total
Sample size 10 9 19
Target region size per sample (bp) 44,234,141 44,131,461
Average SD Total
Raw data yield (Gb) 6.530 0.383 124.069
Data mapped to target region (Gb) 3.110 0.221 59.097
Mean depth of target region 70.40 5.05 1,337.54
Coverage of target region (%) 99.32 0.06
Fraction of target covered .= 10X 95.12 0.51
Fraction of target covered .= 20X 88.18 1.34
Fraction of target covered .= 30X 78.78 2.35
Fraction of target covered .= 50X 57.20 3.86
Fraction of target covered .= 70X 41.44 1.63
Rate of nucleotide mismatch (%) 0.22 0.02
doi:10.1371/journal.pone.0092298.t002
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and metabolic pathways) in whole-exome sequencing. In further
validation analysis, three SNPs (rs7745040, rs9275295, and
rs9473132) in two genes (HLA-DRB1 and CD2AP) were
confirmed to be associated with KBD.
HLA-DRB1 belongs to the HLA class II beta chain paralogs.
The class II molecule is a heterodimer comprising an alpha (DRA)
and a beta chain (DRB), both anchored in the cell membrane.
This molecule is central to the immune system because it presents
peptides derived from extracellular proteins. OA and RA have
been associated with individual immune response. HLA-DRB1
has been associated with OA [16], RA [14–16], and KBD [17].
The finding of this study correlates with that of previous studies,
which supports the association of HLA-DRB1 with KBD as well as
the autoimmune disease hypothesis of KBD [17]. Seven delete-
rious calling SNPs were found in the HLA-DRB1 exome area
based on the results of whole-exome sequencing (Table S3).
Further studies on HLA-DRB1 in KBD and on the functional
characterization of these SNPs are needed.
CD2AP is a 639-amino acid adapter protein, which is a
scaffolding molecule expressed in all tissues except in the brain that
regulates the actin cytoskeleton [18]. The protein harbors three
SH3 domains in its N terminus, a proline rich domain and a C-
terminal leucine-zipper domain via which it can homodimerize
[19]. Common variations of CD2AP have been associated with
kidney problems and late-onset Alzheimer’s diseases [20,21], in
which CD2AP was found to be involved in the abnormal
cytoskeletal structural regulation and cell–cell contacts [22,23].
In KBD, studies on proteomics and transcriptional expression
profiles show far-ranging abnormal of cytoskeletal structural
[4,24]. KEGG pathway analysis indicates a large range of
abnormal genes distributed in the pathway of regulation of the
actin cytoskeleton (Table S2). The CD2AP gene is also involved in
the lymphocyte signaling, which is connected with T cell immune
response. However, whether CD2AP variations are associated
with the change in the cytoskeletal structural of KBD patients as
well as the function of CD2AP in KBD require further
investigation.
In the first stage of this study, the whole-exome sequencing of 19
individuals showed a number of important signals in other
chromosomal regions or genes, except for those discussed above.
However, the follow-up investigation in independent replication
did not confirm the significant association. First, the most
significant p-value sites concentrated on the 19q13.2 (chr19:
38742846-54254388), which contain the SELV and TRNAU1
gene. The biological functions of SELV have been less character-
ized, but a redox function has been suggested [25,26]. TRNAU1
may be associated with KBD, given that a mouse model
demonstrated that the deletion of SelenocysteinetRNATrsp may
result in pathological features of KBD [27]. Epidemiological
investigation of environmental risks has shown that selenium
deficiency may contribute to the etiopathogenesis of KBD [28].
This association was not identified in the current study possibly
because of the small sample size in the validation study or the false-
positive results in the first stage. Second, previous studies have
shown that inflammatory factors, such as IL-1b, IL-6, and TNF-a,
are involved in the pathological mechanisms of KBD. Similarly, in
the current study, IL4R, CD22, CD82, CD163L1, CD180,
IL12A, HLA-F-AS1, CD2AP, and HLA-DPB1 genes were found
to be associated with KBD. Considering the association of HLA-
DRB1 with KBD, two SNPs (rs7745040 and rs9275295) in HLA-
DRB1 were chosen for the second stage of this study because of
the significant p-value found in HLA-DPB1 gene located near
HLA-DRB1, considering the possibility of linkage disequilibrium.
Results indicate that two genes (HLA-DRB1and CD2AP) were
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identified to be positively associated with KBD. For other
unidentified inflammatory factors, genes may show a false-positive
association in the first stage because genes that are related to the
immune system show far-ranging variations in human beings.
Third, KEGG pathway analysis indicated that numerous genes
concentrated on the regulation of actin cytoskeleton, focal
adhesion, and metabolic pathways. Studies on transcription and
protein expression profiling implied that expression of numerous
genes and related proteins can be associated with these pathways
[17,27,28]. However, no positive association was found in the
present validation study. These pathways might represent far-
reaching human physiological and metabolic pathways without
any KBD-specific performance.
In this study, the susceptibility genes of KBD with whole-exome
sequencing technology were comprehensively investigated. The
findings obtained in this study can provide first-hand genetic
information for the identification of the etiological mechanism of
complex diseases. However, a number of limitations should be
considered in relation to present results. First, the statistical power
of this study is relatively low due to the small sample size either in
the stage of whole-exome sequencing or in the replication stage in
case-control analysis. Only 19 samples were used for the whole-
exome sequencing, which is relatively small. The small size of the
sample may provide false-positive results in the TDT test in the
first stage of this study and may also increase the difficulty in
selecting SNPs for the validation study. Second, only 44 SNPs
distributed in 41 genes were chosen and tested in the validation
stage. Although the selection of these genes was based on previous
studies, which indicated that such genes/loci were found to cause
KBD, the possible susceptibility of other genes cannot be
excluded. Future studies should increase the sample size in
whole-exome sequencing, and further studysuch as functional
analysis of these genes should be carried out in order to identify
therole of susceptibility genes in KBD.
In summary, HLA-DRB1 and CD2AP were identified to be the
susceptibility genes of KBD, thus supporting the role of
autoimmune response in KBD and the possibility of shared
etiology between OA, RA, and KBD.
Supporting Information
Figure S1 181,870 of these SNP loci were used in the
TDT test, resulting 108 SNPs with p-value,0.01 and
1056 SNPs with p-value,0.05. This figure shows every SNP
distribution in chromosome. The vertical axis represents log value
after TDT test, and the horizontal axis represents 22 autosomes of
human beings.
(TIF)
Table S1 44 SNPs from 41 genes were employed for
validation.
(XLSX)
Table S2 KEGG pathway analysis indicates that many
genes with significant P value in the test focus on three
major pathways.
(XLSX)
Table S3 Sequencing of HLA-DRB1 gene analysis found
seven deleterious SNP distributed in exome area, this
table listed all genotype distribution in 19 samples in the
first stage of research.
(XLSX)
Table S4 All significant SNPs with P value,0.05 from
the TDT test of exome sequencing.
(XLSX)
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